BOHEMIA, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced results
for the fiscal first quarter ended December 31, 2007. For the
fiscal first quarter ended December 31, 2007, net sales were $511
million compared to $506 million for the fiscal first quarter ended
December 31, 2006, an increase of $5 million or 1%. Net income for
the fiscal first quarter ended December 31, 2007 was $46 million,
or $0.67 per diluted share, compared to $51 million, or $0.73 per
diluted share, for the fiscal first quarter ended December 31,
2006. This reflects the decrease in earnings in the Direct
Response/E-Commerce division. Adjusted EBITDA for the fiscal first
quarter of 2008 was $87 million. At December 31, 2007, NBTY had
total assets of $1.6 billion and working capital of $603 million,
of which $236 million consisted of cash and short-term investments.
The Company is committed to using its cash and leverage to increase
shareholder value through opportunistic acquisitions and stock
repurchases. In October 2007, NBTY purchased in open market
transactions 296 thousand shares of its common stock for
approximately $11 million dollars. These shares were purchased
under an existing publicly announced authorization. NBTY
anticipates continuing such purchases on an opportunistic basis.
Based on market conditions, these repurchases may be greater than
historical repurchases. OPERATIONS FOR THE FISCAL FIRST QUARTER
ENDED DECEMBER 31, 2007 Net sales for the Wholesale/US Nutrition
division, which markets Nature's Bounty, Solgar, Osteo Bi-Flex,
Rexall, Ester-C and other brands, increased $12 million or 5% to
$259 million from $247 million for the prior like quarter. Gross
profit for the Wholesale operation increased to 44%, compared with
40% for the prior like quarter, reflecting greater efficiencies in
supply chain management. The Company is currently experiencing
higher purchase prices of certain raw materials. It is anticipated
that a portion of these cost increases will be reflected in the
prices of the Company's products. The Wholesale/US Nutrition
division utilizes valuable consumer preference sales data generated
by the Company's Vitamin World retail stores and Puritan's Pride
Direct Response/E-Commerce operations to empower its wholesale
customers with this latest data. The Vitamin World stores are used
as a laboratory for new ideas and are an effective tool in
determining and monitoring consumer preferences. This information,
as well as scanned sales data from the Vitamin World stores, is
shared on a real time basis with our wholesale customers to give
them a competitive advantage. Net sales for the North American
Retail division increased $1 million, or 2% to $56 million for the
fiscal first quarter ended December 31, 2007 compared with $55
million for the prior like quarter. While Adjusted EBITDA was
positive, this division operated at an approximate $1 million loss.
Same store sales for North American Retail increased 6% for the
fiscal first quarter of 2008. The North American Retail division
continues to focus on rationalizing SKU's, enhancing visual
merchandising and increasing customer traffic. During the fiscal
first quarter of 2008, the North American Retail division closed 5
under-performing stores and added 2 new stores. At the end of the
fiscal first quarter, the North American Retail division operated a
total of 534 stores consisting of 454 Vitamin World stores in the
United States and 80 LeNaturiste stores in Canada. During the
remainder of fiscal 2008, Vitamin World anticipates closing
approximately 18 under-performing stores and opening approximately
10 stores. European Retail net sales for the fiscal first quarter
of 2008 increased $6 million, or 4% to $159 million from $153
million for the prior like period. European Retail division same
store sales in local currency decreased 4%. The European Retail
division continues to leverage its premier status, high street
locations and brand awareness in a difficult retail environment.
The European Retail division consists of 514 Holland & Barrett
and 31 GNC stores in the UK, 19 Nature's Way stores in Ireland, and
70 DeTuinen stores in the Netherlands for a total of 634 stores.
During the fiscal first quarter of 2008 the European Retail
division opened 8 stores. Net sales from Direct Response/E-Commerce
operations for the fiscal first quarter of 2008 decreased $14
million, or 28% to $37 million from $52 million for the fiscal
first quarter of 2007. This division varies its promotional
strategy throughout the fiscal year. In the fiscal first quarter
2007, Direct Response utilized a highly promotional priced catalog
which was not offered in the currently reported quarter. Therefore,
in this less promotional quarter, Direct Response realized lower
results. Direct Response's historical results reflect this pattern
and should therefore be viewed on an annual and not quarterly
basis. The Direct Response operations include catalog and online
internet sales. This Division's strategic plan is to increase
internet sales by continuing to incorporate new technologies. For
this fiscal first quarter online sales increased to 40% of total
Direct Response/E-Commerce sales compared to 36% for the fiscal
first quarter of 2007. NBTY remains the leader in the direct
response and e-commerce sectors and continues to increase the
number of products available via its catalog and web sites. NBTY
Chairman and CEO, Scott Rudolph, said: "NBTY maintained its
leadership position. We are confident that the initiatives we
instituted in our direct response business will be the cornerstone
for generating positive results. We continue to enhance our
position as the global leader in the nutritional supplement
industry and take steps to best respond to cyclical changes in
industry segments and garner greater market share." ABOUT NBTY NBTY
is a leading global vertically integrated manufacturer, marketer
and distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. Under a number of NBTY and third party brands, the Company
offers over 22,000 products, including products marketed by the
Company's Nature's Bounty(R) (http://www.naturesbounty.com/),
Vitamin World(R) (http://www.vitaminworld.com/), Puritan's Pride(R)
(http://www.puritan.com/), Holland & Barrett(R)
(http://www.hollandandbarrett.com/), Rexall(R)
(http://www.rexallsundown.com/), Sundown(R)
(http://www.rexallsundown.com/), MET-Rx(R) (http://www.metrx.com/),
WORLDWIDE Sport Nutrition(R) (http://www.sportnutrition.com/),
American Health(R) (http://www.americanhealthus.com/), GNC (UK)(R)
(http://www.gnc.co.uk/), DeTuinen(R) (http://www.detuinen.nl/),
LeNaturiste(TM) (http://www.lenaturiste.com/), SISU(R)
(http://www.sisu.com/), Solgar(R) (http://www.solgar.com/) and
Ester-C(R) (http://www.ester-c.com/) brands. This release refers to
non-GAAP financial measures, such as Adjusted EBITDA. "Adjusted
EBITDA" is defined as net income, excluding the aggregate amount of
all non-cash losses reducing net income, plus interest, taxes,
depreciation and amortization. This non-GAAP financial measure is
not prepared in accordance with generally accepted accounting
principles and may be different from non-GAAP financial measures
used by other companies. Non-GAAP financial measures should not be
considered as a substitute for, or superior to, measures of
financial performance prepared in accordance with GAAP. A
reconciliation of the non-GAAP measure to the comparable GAAP
measure is included in the attached financial tables. Management
believes the presentation of Adjusted EBITDA is relevant and useful
because Adjusted EBITDA is a measurement industry analysts utilize
when evaluating NBTY's operating performance. Management also
believes Adjusted EBITDA enhances an investor's understanding of
NBTY's results of operations because it measures NBTY's operating
performance exclusive of interest and non-cash charges for
depreciation and amortization. Management also provides this
non-GAAP measurement as a way to help investors better understand
its core operating performance, enhance comparisons of NBTY's core
operating performance from period to period and to allow better
comparisons of NBTY's operating performance to that of its
competitors. This release contains certain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 with respect to our financial condition, results
of operations and business. These forward-looking statements can be
identified by the use of terminology such as "subject to,"
"believe," "expects," "plan," "project," "estimate," "intend,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy. Although all of these forward looking
statements are believed to be reasonable, they are inherently
uncertain. Factors which may materially affect such forward-looking
statements include: (i) slow or negative growth in the nutritional
supplement industry; (ii) interruption of business or negative
impact on sales and earnings due to acts of God, acts of war,
terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and/or unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance and/or the costs of the same; (xiv) exposure to and
expense of defending and resolving product liability and
intellectual property claims and other litigation; (xv) the ability
of NBTY to successfully implement its business strategy; (xvi) the
inability of NBTY to manage its retail, wholesale, manufacturing
and other operations efficiently; (xvii) consumer acceptance of
NBTY's products; (xviii) the inability of NBTY to renew leases for
its retail locations; (xix) the inability of NBTY's retail stores
to attain or maintain profitability; (xx) the absence of clinical
trials for many of NBTY's products; (xxi) sales and earnings
volatility and/or trends for the Company and its market segments;
(xxii) the efficacy of NBTY's Internet and on-line sales and
marketing strategies; (xxiii) fluctuations in foreign currencies,
including the British Pound, the Euro and the Canadian dollar;
(xxiv) import-export controls on sales to foreign countries; (xxv)
the inability of NBTY to secure favorable new sites for, and delays
in opening, new retail and manufacturing locations; (xxvi)
introduction of and compliance with new federal, state, local or
foreign legislation or regulation or adverse determinations by
regulators anywhere in the world (including the banning of
products) and more particularly Good Manufacturing Practices in the
United States, the Food Supplements Directive and Traditional
Herbal Medicinal Products Directive in Europe and Section 404
requirements of the Sarbanes-Oxley Act of 2002; (xxvii) the mix of
NBTY's products and the profit margins thereon; (xxviii) the
availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased
energy prices and potentially reduced traffic flow to NBTY's retail
locations; (xxxi) adverse tax determinations; (xxxii) the loss of a
significant customer of the Company; (xxxiii) potential investment
losses as a result of liquidity conditions; and (xxxiv) other
factors beyond the Company's control. Readers are cautioned not to
place undue reliance on forward-looking statements. NBTY cannot
guarantee future results, trends, events, levels of activity,
performance or achievements. NBTY does not undertake and
specifically declines any obligation to update, republish or revise
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrences of unanticipated
events. Consequently, such forward-looking statements should be
regarded solely as NBTY's current plans, estimates and beliefs.
Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz &
Co. President and Chief Financial Officer 212-725-4500 631-200-2020
NBTY, Inc. and Subsidiaries Condensed Consolidated Statements of
Income (Unaudited) (In thousands, except per share amounts) For the
three months ended December 31, 2007 2006 Net sales $510,858 $
506,237 Costs and expenses: Cost of sales 240,331 247,047
Advertising, promotion and catalog 34,169 26,763 Selling, general
and administrative 168,123 151,939 442,623 425,749 Income from
operations 68,235 80,488 Other income (expense): Interest (3,862)
(5,063) Miscellaneous, net 4,887 1,339 1,025 (3,724) Income before
provision for income taxes 69,260 76,764 Provision for income taxes
23,438 25,908 Net income $45,822 $50,856 Net income per share:
Basic $0.68 $0.76 Diluted $0.67 $0.73 Weighted average common
shares outstanding: Basic 66,903 67,213 Diluted 68,786 69,331 SALES
(Unaudited) THREE MONTHS ENDED DECEMBER 31, Percentage (In
thousands) 2007 2006 Change Wholesale / US Nutrition $258,935
$246,728 5% North American Retail 56,182 54,973 2% European Retail
158,597 152,966 4% Direct Response / E-Commerce 37,144 51,570 -28%
Total $510,858 $506,237 1% GROSS PROFIT PERCENTAGES (Unaudited)
THREE MONTHS ENDED DECEMBER 31, Increase 2007 2006 - Decrease
Wholesale / US Nutrition 44% 40% 4% North American Retail 59% 60%
-1% European Retail 63% 63% 0% Direct Response / E-Commerce 63% 62%
1% Total 53% 51% 2% ADJUSTED EBITDA** Reconciliation of GAAP
Measures to Non-GAAP Measures (Unaudited) (In thousands) THREE
MONTHS ENDED DECEMBER 31, 2007 Pretax Depreciation Income and
Non-cash Adjusted (Loss) amortization Interest charges EBITDA**
Wholesale / US Nutrition $53,981 $2,694 $- $- $56,675 North
American Retail (864) 850 350 336 European Retail 35,067 3,063
38,130 Direct Response / E-Commerce 7,123 1,366 8,489 Segment
Results 95,307 7,973 - 350 103,630 Corporate / Manufacturing
(26,047) 5,959 3,862 - (16,226) Total $69,260 $13,932 $3,862 $350
$87,404 THREE MONTHS ENDED DECEMBER 31, 2006 Pretax Depreciation
Income and Non-cash Adjusted (Loss) amortization Interest charges
EBITDA** Wholesale / US Nutrition $49,589 $2,789 $- $- $52,378
North American Retail 1,087 1,137 - 353 2,577 European Retail
38,824 2,828 - - 41,652 Direct Response / E-Commerce 15,593 1,265 -
- 16,858 Segment Results 105,093 8,019 - 353 113,465 Corporate /
Manufacturing (28,329) 6,212 5,063 - (17,054) Total $76,764 $14,231
$5,063 $353 $96,411 ** SINCE ADJUSTED EBITDA IS NOT A MEASURE OF
PERFORMANCE CALCULATED IN ACCORDANCE WITH U.S. GENERALLY ACCEPTED
ACCOUNTING PRINCIPLES ("GAAP"), IT SHOULD NOT BE CONSIDERED IN
ISOLATION OF, OR AS A SUBSTITUTE FOR OR SUPERIOR TO, OTHER MEASURES
OF FINANCIAL PERFORMANCE PREPARED IN ACCORDANCE WITH GAAP, SUCH AS
OPERATING INCOME, NET INCOME AND CASH FLOWS FROM OPERATING
ACTIVITIES. IN ADDITION, THE COMPANY'S DEFINITION OF ADJUSTED
EBITDA IS NOT NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES
REPORTED BY OTHER COMPANIES. NBTY, Inc. and Subsidiaries Condensed
Consolidated Balance Sheets (Unaudited) (Dollars and shares in
thousands, except per share amounts) December 31, September 30,
2007 2007 Current assets: Cash and cash equivalents $98,941 $92,902
Investments 137,301 121,382 Accounts receivable, net 111,226 98,454
Inventories 390,321 384,990 Deferred income taxes 21,856 21,441
Prepaid expenses and other current assets 52,825 54,460 Total
current assets 812,470 773,629 Property, plant and equipment, net
323,193 323,154 Goodwill 248,614 251,753 Intangible assets, net
159,045 157,548 Other assets 29,386 28,851 Total assets $1,572,708
$1,534,935 Current liabilities: Current portion of long-term debt
$1,008 $989 Accounts payable 72,931 71,852 Accrued expenses and
other current liabilities 135,658 125,533 Total current liabilities
209,597 198,374 Long-term debt, net of current portion 209,400
210,106 Deferred income taxes 58,272 61,788 Other liabilities
11,586 8,697 Total liabilities 488,855 478,965 Commitments and
contingencies Stockholders' equity: Common stock, $0.008 par;
authorized 175,000 shares; issued and outstanding 66,822 shares at
December 31, 2007 and 67,118 shares at September 30, 2007 535 537
Capital in excess of par 142,864 143,244 Retained earnings 897,516
864,852 Accumulated other comprehensive income 42,938 47,337 Total
stockholders' equity 1,083,853 1,055,970 Total liabilities and
stockholders' equity $1,572,708 $1,534,935 NBTY, Inc. and
Subsidiaries Condensed Consolidated Statements of Cash Flows
(Unaudited) (In thousands) For the three months ended December 31,
2007 2006 Cash flows from operating activities: Net income $45,822
$50,856 Adjustments to reconcile net income to cash and cash
equivalents provided by operating activities: Impairments and
disposals of property, plant and equipment 462 392 Depreciation and
amortization 13,932 14,231 Foreign currency transaction (gain) loss
(1,299) 318 Amortization and write-off of deferred charges 152
1,303 Amortization of bond discount 34 31 Allowance for doubtful
accounts (229) (135) Inventory reserves 1,061 2,292 Deferred income
taxes 449 3,886 Excess income tax benefit from exercise of stock
options (88) (20) Changes in operating assets and liabilities, net
of acquisitions: Accounts receivable (11,789) (2,516) Inventories
(7,784) (5,087) Prepaid expenses and other current assets 1,275
4,443 Other assets (490) (163) Accounts payable 687 2,834 Accrued
expenses and other liabilities 7,842 10,241 Net cash provided by
operating activities 50,037 82,906 Cash flows from investing
activities: Purchase of property, plant and equipment (9,814)
(6,212) Purchase of available-for-sale investments (55,148)
(214,718) Proceeds from sale of available-for-sale investments
39,272 154,844 Cash paid for acquisitions, net of cash acquired
(5,072) (38,219) Cash collateral securing loan - (18,360) Net cash
used in investing activities (30,762) (122,665) Cash flows from
financing activities: Principal payments under long-term debt
agreements and capital leases (239) (196) Payments for financing
fees - (1,649) Excess income tax benefit from exercise of stock
options 88 20 Proceeds from stock options exercised - 12 Purchase
of treasury stock (subsequently retired) (10,603) - Net cash used
in financing activities (10,754) (1,813) Effect of exchange rate
changes on cash and cash equivalents (2,482) 1,763 Net increase
(decrease) in cash and cash equivalents 6,039 (39,809) Cash and
cash equivalents at beginning of the period 92,902 89,805 Cash and
cash equivalents at end of the period $98,941 $49,996 DATASOURCE:
NBTY, Inc. CONTACT: Harvey Kamil, President and Chief Financial
Officer of NBTY, Inc., +1-631-200-2020, or Carl Hymans of G.S.
Schwartz & Co., +1-212-725-4500, or , for NBTY, Inc. Web site:
http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024